 (NaturalNews) Earlier this week the pharmaceutical firm Genentech announced that it would institute a price cap for its cancer drug Avastin at $55,000 per year for patients with a household income of less than $75,000 a year.
Genentech's announcement follows a decision by rival drug company Amgen two weeks ago to begin selling its colon cancer drug Vectibix at $4,000 per dose -- about 20 percent lower than the price of Bristol-Myers Sqibb's similar drug Erbitux.
The price cap for Avastin comes after the U.S. Food and Drug Administration (FDA) approved Genentech's drug for another use, in non-small cell lung cancer. Doctors had complained that the price of Avastin was too high for most cancer patients.
Leonard Saltz, a colon cancer specialist at Memorial Sloan-Kettering Hospital, said, "[The price cap] really makes me feel that [drug companies are] at least getting the message that the gravy train is starting to slow down." Saltz said that even with Genentech's price cap in place, the cost of Avastin is still "egregiously high," and cancer drugs in general represent "an unconscionable price gouging."
Genentech spokeswoman Debra Charlesworth said the price cap is "one step" in the company's efforts to make cancer drugs more affordable for patients. Since the last quarter of 2005, Genentech has donated $50 million to various charities to help patients cover the high copays on cancer drugs, including those not made by Genentech.
Charlesworth says the price cap was initiated because patients with different forms of cancer that Avastin has been approved to treat can end up paying vastly different prices. For example, lung cancer patients treated with Avastin pay $56,000 per year on average, while colon cancer patients pay $44,000. Breast cancer patients are generally treated for 11 months, and would likely hit the price cap after about six months, meaning the second half of their treatment would be free.
Although many Genentech investors see the price cap as "good P.R.," others believe the company's efforts to control cancer drug prices will hurt its shares.
Consumer health advocate Mike Adams, author of "Take Back Your Health Power," says cancer patients are paying unacceptable prices for drug therapies.
"The cancer industry preys upon the fear of society's most vulnerable patients, transforming human beings into profit-generating machines, even as their drugs usually offer no measurable benefit whatsoever," Adams said.
###
Related Articles
• The mineral selenium proves itself as powerful anti-cancer medicine
• Cancer is not a Disease - It's a Survival Mechanism (Book Excerpt)
• New research shows vitamin D slashes risk of cancers by 77 percent; cancer industry refuses to support cancer prevention
• Mammograms cause breast cancer (and other cancer facts you probably never knew)
• Breast Cancer Industry A Scam? Support Education, Not Medication
 |
Additional Resources:
cancer
Genentech
avastin
|
Take Action: Support NaturalNews.com
 Email this article to a friend
 Share this article on: NewsVine | digg | del.icio.us
Permalink to this article: http://www.NaturalNews.com/020763.html
Reprinting this article: Non-commercial OK, cite NaturalNews.com with clickable link.
|
 |
 |
Receive our Natural Health Newsletter for FREE
 Subscribe now (it's free!) to win. We randomly choose a subscriber each month to send $100 in eco-home products or a RealGoods.com gift certificate (our choice). Plus, you'll receive FREE news, articles and action alerts from NaturalNews.com editors and join over 800,000 monthly readers who report extraordinary health improvements after becoming a subscriber!
- Receive breaking news alerts on natural health solutions, renewable energy, the environment, global warming and more.
- Receive a free instant download of our $29 Secret Sources guide that reveals top sources for little-known health and diet solutions.
|
|
 |
 |
Recommended Special Report:
 Seven Words that can Change the World
by Joseph R. Simonetta
Read this special report now...
"Seven Words That Can Change the World reveals the astonishing, simple truths that have the power to forever transform our world for the better while freeing our minds from the enslavement of limiting beliefs. This is not a text for the simple-minded; it is a guiding philosophy for the mindful, intelligent few who are wise enough to seek out -- and recognize -- the higher simplicities of truly purposeful living." - Mike Adams, the Health Ranger, editor of NaturalNews.com
|
More on NaturalNews.com:
• Streaming Health Ranger Videos
• CounterThink Cartoons
• FREE Special Reports
• Podcasts
|
 |
|
Printable Version
